EPIDURAL MORPHINE

Course overview

EPIDURAL MORPHINE IS A MEDICATION USED FOR ANALGESIA, WHETHER AS AN ADJUNCT TO GENERAL ANESTHESIA OR AS THE SOLE TECHNIQUE FOR SURGICAL ANESTHESIA. THIS MEDICATION IS THE FIRST OPIOID APPROVED FOR NEURAXIAL ADMINISTRATION BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA). EPIDURAL MORPHINE HAS BEEN THE MOST WIDELY UTILIZED OPIOID IN CLINICAL PRACTICE WHEN ADMINISTERED VIA THIS ROUTE. IN 2004, LIPOSOME-BASED EXTENDED-RELEASE EPIDURAL MORPHINE (EREM) ALSO RECEIVED FDA APPROVAL. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR EPIDURAL MORPHINE AS A VALUABLE AGENT FOR TREATING ACUTE AND CHRONIC MODERATE-TO-SEVERE PAIN. FURTHERMORE, THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER CRUCIAL FACTORS, SUCH AS DOSING, PHARMACOKINETICS, MONITORING, CONTRAINDICATIONS, AND TOXICITY, PERTINENT FOR INTERPROFESSIONAL TEAM MEMBERS IN MANAGING EPIDURAL MORPHINE IN PATIENTS RECEIVING THE MEDICATION.